Mode
Text Size
Log in / Sign up
N/A N=40 Randomized Double-blind Treatment

Fitting Evaluation of Hydrogel and Silicone Hydrogel Sphere Design Contact Lenses

Myopia

Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Apr 2019
Primary outcome: Primary: Visual Acuity — -0.04; -0.05; -0.03; -0.01 logMAR

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Omafilcon A (Device); Somofilcon A (Device); Omafilcon A - Proclear (PC) (Device)
Age
Adult · 18+ yrs
Sex
All
Sponsor
CooperVision, Inc.
Primary completion
Mar 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Visual Acuity
-0.04; -0.05; -0.03; -0.01; -0.01; -0.01
PRIMARY
Comfort
94.5; 98.0; 94.7; 95.8; 96.8; 93.7
PRIMARY
Lens Centration
40; 40; 40; 0; 0; 0
PRIMARY
Lens Centration
40; 40; 40; 0; 0; 0
PRIMARY
Post-blink Lens Movement
0; 1; 0; 7; 1; 4
PRIMARY
Post-blink Lens Movement
0; 1; 0; 7; 1; 4
PRIMARY
Lens Fit Acceptance
0; 1; 0; 0; 0; 4
PRIMARY
Lens Fit Acceptance
0; 1; 0; 0; 0; 4
PRIMARY
Lens Fit Preference
5; 2; 6; 27
PRIMARY
Limbal Redness
0.41; 0.39; 0.39
PRIMARY
Bulbar Redness
0.51; 0.55; 0.50

Summary

The aim of this non-dispensing fitting study is to evaluate the short term lens fit, vision performance of three monthly replacement sphere lenses.

Eligibility Criteria

Inclusion Criteria

  • A person is eligible for inclusion in the study if he/she:
  • Is between 18 and 40 years of age (inclusive).
  • Has had a self-reported visual exam in the last two years.
  • Is an adapted soft CL (Contact Lens) wearer who is not wearing any of the study lenses.
  • Has a CL spherical prescription between - 1.00 and - 6.00 (inclusive)
  • Has a spectacle cylinder up to 0.75D (Diopter) in each eye.
  • Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
  • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
  • Has clear corneas and no active ocular disease.
  • Has read, understood and signed the information consent letter.
  • Patient contact lens refraction should fit within the available parameters of the study lenses.
  • Is willing to comply with the wear schedule.
  • Is willing to comply with the visit schedule.

Exclusion Criteria

  • A person will be excluded from the study if he/she:
  • Has never worn contact lenses before.
  • Currently wears rigid gas permeable contact lenses.
  • Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)
  • Has a CL prescription outside the range of - 1.00 to - 6.00D
  • Has a spectacle cylinder ≥1.00D of cylinder in either eye.
  • Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye.
  • Presence of clinically significant (grade 2-4) anterior segment abnormalities.
  • Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear.
  • Slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Pterygium, pinguecula, or corneal scars within the visual axis
  • Neovascularization > 0.75 mm in from of the limbus
  • Giant papillary conjunctivitis (GCP) worse than grade 1
  • Anterior uveitis or iritis (past or present)
  • Seborrheic eczema, Seborrheic conjunctivitis
  • History of corneal ulcers or fungal infections
  • Poor personal hygiene
  • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)
  • Has aphakia, keratoconus or a highly irregular cornea.
  • Has Presbyopia or has dependence on spectacles for near work over the contact lenses.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye related clinical or research study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03098745). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search